RXi Pharmaceuticals (RXII) Reports Full Year 2012 Financial Results  
3/29/2013 6:26:53 AM

RXi Pharmaceuticals Corporation (OTC: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today reported its financial results for the full year 2012, and provided a business update.